Author

Raquel Pluvinet

Josep Carreras Leukaemia Research InstituteORCID 0000-0002-4955-8238Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1

Frequent Co-Authors

Manel EstelleriD· 3 shared Aleix Noguera‐CastellsiD· 2 shared Aaron James StonestromiD· 1 shared Ahmet ZehiriD· 1 shared Aishwarya KrishnaniD· 1 shared Alberto Bueno Costa· 1 shared Alberto Bueno-CostaiD· 1 shared Aleix LluansíiD· 1 shared

Activity by Year

2024-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Manel EstellerORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintSep 10, 2025

METTL3-mediated m6A modification of DNMT1 enhances ovarian cancer progression

Kanchan Kumari, Iván Pérez-Núñez, Aleix Noguera‐Castells…·Francesca Aguiló

This study identifies METTL3-mediated m6A modification of DNMT1 as a driver of ovarian cancer progression by enhancing DNMT1 translation and suppressing tumor suppressors.

DOI 10.1101/2025.09.10.675425

humanDNA methylation

𝕏 PostBluesky

GenomicsbioRxivPreprintFeb 24, 2025

The Multiomics Blueprint of Extreme Human Lifespan

Eloy Santos-Pujol, Aleix Noguera‐Castells, Marta Casado-Peláez…·Manel Esteller

This study presents a multi-omics analysis of a supercentenarian, revealing that extreme age and poor health are distinct molecular processes.

2 citations

humanwhole-genome sequencing

𝕏 PostBluesky

Cancer BiologybioRxivPreprintOct 10, 2024

Targetable Treatment Resistance in Thyroid Cancer with Clonal Hematopoiesis

Vera Tiedje, Pablo Sánchez Vela, Julie L. Yang…·Ross L. Levine

This study identifies TET2-mutant clonal hematopoiesis in thyroid cancer microenvironments and shows that TGFβ signaling from these macrophages mediates resistance to BRAF/MEK inhibition, with TGFβ inhibition restoring sensitivity.

9 citations

mousehuman

𝕏 PostBluesky